I'm looking for references on the minimal requirements for dimerization of the FIV genome. From what I understand, the FIV genome is composed of 2 RNA constructs that are dimerized before being packaged in the capsid. I want to know if both constructs contain essential elements for FIV replication. Or is one construct sufficient, while the other might be replaced with a therapeutic cargo?

Ultimately, I'm trying to find out how much of the FIV genome is available for incorporating heterologous genetic material.

Any Direction Welcome.

More Laura Prendergast's questions See All
Similar questions and discussions